Clinical Performance Study Protocol for Therascreen KRAS RGQ PCR Kit

ABSTRACT: An interventional, prospective clinical performance study protocol, for the testing of DNA extracted from tumor tissue biopsy samples, using the therascreen KRAS RGQ PCR Kit, from patients with Non-Small Cell Lung Cancer and Colorectal Cancer, screened in Amgen’s clinical trial (Protocol No. 20170543).

DISEASE(S): Colorectal Cancer,Non-small Cell Lung Cancer,Colorectal Neoplasms,Carcinoma, Non-small-cell Lung,Lung Neoplasms

PROVIDER: 2720328 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR